NCT05537779View on ClinicalTrials.gov

Safety and Performance of Optivantage Multi-use When Injecting Contrast Media for Contrast Enhanced CT Examination

UnknownOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

January 31, 2023

Conditions
Patient Participation
Interventions
DEVICE

CT examination

Administration of contrast medium using the power injector

Sponsors

Lead Sponsor

Guerbet
All Listed Sponsors
lead

Guerbet

INDUSTRY

NCT05537779 - Safety and Performance of Optivantage Multi-use When Injecting Contrast Media for Contrast Enhanced CT Examination | Biotech Hunter | Biotech Hunter